ReoPro abciximab: Marketed

Additional data from CNTO's Phase III CAPTURE study of patients with unstable angina undergoing angioplasty were published in The New England Journal of Medicine, showing that patients with elevated serum cardiac troponin T levels are at higher risk for cardiovascular events (death or myocardial infarction) and would particularly benefit from ReoPro. ...